Synthesis, toxicology and potential of ordered mesoporous materials in nanomedicine

Nanomedicine

Volumn 6, Issue 5, 2011, Pages 867-877

  Garcia Bennett, Alfonso E ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

cellular targeting; drug delivery; excipients; formulation; mesoporous materials; silica; theranostics

Indexed keywords

FOOD ADDITIVE; SILICON DIOXIDE; SURFACTANT;

DRUG DELIVERY SYSTEM; DRUG FORMULATION; NANOMEDICINE; NONHUMAN; PARTICLE SIZE; POROSITY; PRIORITY JOURNAL; REVIEW; SYNTHESIS;

ANIMALS; DRUG DELIVERY SYSTEMS; HUMANS; NANOMEDICINE; NANOSTRUCTURES; POROSITY; SILICON DIOXIDE;

EID: 79960960167     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.11.82     Document Type: Review

References (83)

1. Mann S. Biomineralization: Principles and Concepts in Bioinorganic Materials Chemistry. Oxford Chemistry Masters, Oxford University Press, Oxford, UK (2001).
2. Denga Y, Markoa M, Buttlea KF, Leitha A, Mieczkowskib M, Mannellac CA. Cubic membrane structure in amoeba (Chaos carolinensis) mitochondria determined by electron microscopic tomography. J. Struct. Biol. 127(3), 231-239 (1999).
3. Kresge CT, Leonowicz ME, Roth J, Vartuli JC, Beck JS. Ordered mesoporous molecular sieves synthesized by a liquid-crystal template mechanism. Nature 359, 710-712 (1992). (Pubitemid 23589384)
4. Hyde S, Andersson A, Larsson K et al. The Language of Shape (1st Edition).Elsevier, NY, USA (1997).
5. Barauskas J, Johnsson M, Joabsson F, Tiberg F. Cubic phase nanoparticles (cubosome): principles for controlling size, structure, and stability. Langmuir 21, 2569-2577 (2005). (Pubitemid 40421910)
6. Taguchi A, Schüth F. Ordered mesoporous materials in catalysis. Microporous Mesoporous Mater. 77, 1-45 (2004). (Pubitemid 39615586)
7. Wu Z, Zhao D. Ordered mesoporous materials as adsorbents. Chem. Commun. (Camb.) 47(12), 3332-3338 (2011).
8. Melde BJ, Johnson BJ, Charles PT. mesoporous silicate materials in sensing. Sensors 8, 5202-5228 (2008).
9. Brady R, Woonton B, Gee ML, O'Connor AJ. Hierarchical mesoporous silica materials for separation of functional food ingredients innovative. Food Sci. Emerg. Technol. 9(2), 243-248 (2008). (Pubitemid 351215971)
10. Lu J, Liong M, Zink JI, Tamanoi F. Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs. Small 3(8), 1341-1346 (2007). (Pubitemid 47245524)
11. Zhou ZY, Zhu SM, Zhang D. Grafting of thermo-responsive polymer inside mesoporous silica with large pore size using ATRP and investigation of its use in drug release. J. Mater. Chem. 17(23), 2428-2433 (2007). (Pubitemid 46884070)
12. Yang Q, Wang SH, Fan PW, Wang LF, Di Y, Lin KF. pH-responsive carrier system based on carboxylic acid modified mesoporous silica and polyelectrolyte for drug delivery. Chem. Mater. 17(24), 5999-6003 (2005). (Pubitemid 41784404)
13. Vivero-Escoto L, Slowing II, Trewyn BG, Lin VSY. Mesoporous silica nanoparticles for intracellular controlled drug delivery. Small 6(18), 1952-1967 (2010).
14. Taylor KML, Kim JS, Rieter WJ, An H, Weili Lin W, Lin W. Mesoporous silica nanospheres as highly efficient MRI contrast agents. J. Am. Chem. Soc. 130 (7), 2154-2155 (2008). (Pubitemid 351287981)
15. Vallet-Regi M. Evolution of bioceramics within the field of biomaterials. Comptes Rendus Chimie 2010, 174-185 (2010).
16. Kuroda K. Silica-based mesoporous molecular sieves derived from a layered polysilicate kanemite - a review. J. Porous Materials 3(2), 107-114 (1996). (Pubitemid 126708537)
17. Brinker CJ, Scherer GW. Sol-Gel Science: The Physics and Chemistry of Sol-Gel Processing. Academic Press, London, UK (1990).
18. Soler-Illia GJ, Sanchez C, Lebeau B, Patarin J. Chemical strategies to design textured materials: from microporous and mesoporous oxides to nanonetworks and hierarchical structures. Chem. Rev. 102(11), 4093-4138 (2002). (Pubitemid 35420908)
19. Tian B, Liu X, Tu B et al. Self-adjusted synthesis of ordered stable mesoporous minerals by acid-base pairs. Nat. Mater. 2(3), 159-163 (2003).
20. Kleitz F. Ordered mesoporous materials. In:Handbook of Heterogeneous Catalysis, 2nd Edition . Ertl G, Knötzinger H, Schüth F, Weitkamp J (Eds).VCH-Wiley, Weinheim, Handbook of Heterogeneous Catalysis. 168-219 (2008).
21. Zhao D, Feng J, Huo Q et al. Triblock copolymer syntheses of mesoporous silica with periodic 50 to 300 angstrom pores. Science 279, 548-552 (1998). (Pubitemid 28067280)
22. Beck JS, Vartuli JC, Roth WJ et al. A new family of mesoporous molecular-sieves prepared with liquid-crystal templates. J. Am. Chem. Soc. 27, 10834-10843 (1992)
23. Yokoi T, Yoshitake H, Tatsumi T. Synthesis of anionic-surfactant- templated mesoporous silica using organoalkoxysilane-containing amino groups. Chem. Mater. 15, 4536-4538 (2003).
24. Che S, Garcia-Bennett AE, Yokoi T et al. A novel anionic surfactant templating route for synthesizing mesoporous silica with unique structure. Nat. Mater. 2, 801-805 (2003).
25. Nnanna IA, Xia J. Protein Based Surfactants: Synthesis, Physicochemical Properties and Applications. Marcel Dekker, NY, USA (2001).
26. Gao C, Che S. Organically functionalized mesoporous silica by co-structure-directing route. Adv. Funct. Mater. 20(17), 2750-2768 (2010).
27. Huo Q, Zhao D, Feng, Kim J, Han Y, Stucky GD. Novel mesoporous silicates with two-dimensional mesostructure direction using rigid bolaform surfactants. Chem. Mater. 11, 2668-2672 (1999). (Pubitemid 129692341)
28. Han Y, Zhang D, Chng LL et al. A tri-continuous mesoporous material with a silica pore wall following a hexagonal minimal surface. Nat. Chem. 1, 123-127 (2009).
29. Huo Q, Leon R, Petroff P, Stucky GD. Mesostructure design with gemini surfactants: supercage formation in a three-dimensional hexagonal array. Science 268, 1324-1327 (1995).
30. Gao C, Sakamoto Y, Sakamoto K, Terasaki O, Che S. Synthesis and characterization of mesoporous silica AMS-10 with bicontinuous cubic Pn3m symmetry. Angew. Chem. Int. Ed. Engl. 45, 4295-4298 (2006). (Pubitemid 44105636)
31. Sakamoto Y, Kaneda M, Terasaki O et al. Direct imaging of the pores and cages of three-dimensional mesoporous materials. Nature 408, 449-453 (2000).
32. Garcia-Bennett AE, Miyasaka K, Che S, Terasaki O. HRTEM structural solution of mesoporous material AMS-8. Chem. Mater. 16, 3597-3605 (2004).
33. Kleitz F, Liu D, Anilkumar GM et al. Large cage face-centered-cubic fm3m mesoporous silica: synthesis and structure. J. Phys. Chem. B 107(51), 14296-14300 (2003).
34. Shen S, Garcia-Bennett AE, Liu Z et al. Three-dimensional low symmetry highly ordered mesoporous silica structures templated with tetra-head group rigid bolaform quaternary ammonium surfactant. J. Am. Chem. Soc. 127, 6780-6787 (2005). (Pubitemid 40664185)
35. Garcia-Bennett AE, Kupferschmidt N, Sakamoto Y, Che S, Terasaki O. Synthesis of mesocage structures by kinetic control of self-assembly in anionic surfactants. Angewandte Chemie International Editions 44, 5451-5456 (2005).
36. Atluri R, Hedin N, Garcia-Bennett AE. Non-surfactant supramolecular synthesis of ordered mesoporous silica. J. Am. Chem. Soc. 131(9), 3189-3191 (2009).
37. Zhou C, Garcia-Bennett AE. Release of folic acid in mesoporous NFM-1 silica. J. Nanosci. Nanotechnol. 10, 1-4 (2010).
38. Qiu H, Xie J, Che S. Formation of chiral mesostructured porphyrin-silica hybrids. Chem. Commun. (Camb.) 47(9), 2607-2609 (2011).
39. Kruc M, Jaroneic M, Sayari A. New insights into pore-size expansion of mesoporous silicates using long-chain amines. Microporous Mesoporous Mater. 35-36, 545-553 (2000). (Pubitemid 30347968)
40. Kruc M, Jaroneic M, Sayari A. adsorption study of surface and structural properties of MCM-41 materials of different pore sizes. J. Phys. Chem. B 101, 583-589 (1997). (Pubitemid 127617367)
41. Thommes M, Smarsly B, Groenewolt M, Ravikovitch PI, Neimark AV. Adsorption hysteresis of nitrogen and argon in pore networks and characterization of novel micro- and mesoporous silicas. Langmuir 22, 756-764 (2006) (Pubitemid 43164813)
42. Ravikovitch PI, Neimark AV. Density functional theory of adsorption in spherical cavities and pore size characterization of templated nanoporous silicas with cubic and three-dimensional hexagonal structures. Langmuir 18(5), 1550-1560 (2002). (Pubitemid 35383958)
43. Miyasaka K, Teresaki O. Self-consistent structural solution of mesoporous crystals by combined electron crystallography and curvature assessment. Angewandte Chemie International Editions 49, 1-6 (2010).
44. Wang X, Lin KSK, Chan JCC, Cheng S. Direct synthesis and catalytic applications of ordered large pore aminopropyl-functionalized SBA-15 mesoporous materials. J. Phys. Chem. B 109(5), 1763-1769 (2005) (Pubitemid 40213178)
45. Atluri R, Sakamoto Y, Garcia-Bennett AE. Co-structure directing agent induced phase transformation of mesoporous materials. Langmuir 25(5), 3189-3195 (2009).
46. Huh S, Wiench JW, Yoo J, Pruski M, Lin V. Organic functionalization and morphology control of mesoporous silicas via a co-condensation synthesis method. Chem. Mater. 15, 4247-4256 (2003).
47. Qu F, Zhu G, Huang S, Li S, Qiu S. Effective controlled release of captopril by silylation of mesoporous MCM-41. ChemPhysChem 7(2), 400-406 (2006).
48. Marschall R, Bannat I, Caro J, Wark M. Proton conductivity of sulfonic acid functionalized mesoporous materials. Microporous Mesoporous Mater. 99, 190-196 (2007). (Pubitemid 46038231)
49. Han L, Sakamoto Y, Tersaki O, Li Y, Che S. Synthesis of carboxylic acid fucntionalised mesoporous silicas (CFMSs) with various structures. J. Mater. Chem. 17, 1216-1221 (2007). (Pubitemid 46412185)
50. Rosenholm JM, Duchanoy A, Lindèn M. Hyperbranching surface polymerization as a tool for preferential functionalization of the outer surface of mesoporous silica. Chem. Mater. 20(3), 1126-1133 (2008). (Pubitemid 351315711)
51. Vallet-Regi M, Balas F, Arcos D. Mesoporous materials for drug delivery. Angewandte Chemie International Editions 46, 7548-7558 (2007). (Pubitemid 47556998)
52. Vallet-Regi M, Ramila A, Real RP, Perez-Pariente J. A new property of MCM-41: drug delivery system. Chem. Mater. 13, 308-312 (2001).
53. Mellaerts R, Mols R, Jammaer JAG et al. Increasing the oral bioavailability of the poorly water soluble drug itraconazole with ordered mesoporous silica. Eur. J. Pharm. Biopharm. 69, 223-230 (2008).
54. Van Speybroeck M, Mellaerts R, Mols R et al. Enhanced absorption of the poorly soluble drug fenofibrate by tuning its release rate from ordered mesoporous silica. Eur. J. Pharm. Biopharm. 21, 623-630 (2010).
55. Andersson J, Rosenholm JM, Areva S, Lindèn M. Influences of material characteristics on ibuprofen drug loading and release profiles from ordered micro- and mesoporous silica matrices. Chem. Mater. 16(21), 4160-4167 (2004).
56. Torney F, Trewyn BG, Lin VSY, Wang K. Mesoporous silica nanoparticles deliver DNA and chemicals into plants. Nat. Nanotechnol. 2, 295-300 (2007). (Pubitemid 46882970)
57. Bhattarai S, Muthuswamy E, Wani A et al. Enhanced gene and siRNA delivery by polycation-modified mesoporous silica nanoparticles loaded with chloroquine. Pharm. Res. 27(12), 2556-2568 (2010).
58. Muñoz B, Perez-Pariente J, Diaz I, Vallet-RegiM. MCM-41 organic modification as drug delivery rate regulator. Chem. Mater. 15(2), 500-503 (2003).
59. Popovici RF, Seftel EM, Miha GD, Popovici E, Voicu VA. Controlled drug delivery system based on ordered mesoporous silica matrices of captopril as angiotensin-converting enzyme inhibitor drug. J. Pharm. Sci. 100, 704-714 (2011).
60. Vallet-Regi M. Nanostructured mesoporous silica matrices in nanomedicine. J. Intern. Med. 267, 22-43 (2010).
61. Rosenholm JM, Duchanoy A, Lindèn M. Towards multifunctional, targeted drug delivery systems using mesoporous silica nanoparticles - opportunities and challenges. Nanoscale 2, 1870-1882 (2010).
62. Strømme M, Brohede U, Atluri R, Garcia-Bennett AE. Mesoporous silica-based nanomaterials for drug delivery: evaluation of structural properties associated with release rate. Wiley Interdiscip. Rev. Nanomed. Nanotechnol. 1(1), 140-148 (2009).
63. Slowing II, Vivero-Escoto JL, Wu CW, Lin VSY. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv. Drug Deliv. Rev.60, 1278-1288 (2008).
64. Mal NK, Fujiwara M, Tanaka Y. Photocontrolled reversible release of guest molecules from coumarin-modified mesoporous silica. Nature 421, 350-353 (2003). (Pubitemid 36157928)
65. Casasus R, Marcos MD, Martinez-Manez R et al. Toward the development of ionically controlled nanoscopic molecular gates. J. Am. Chem. Soc. 126, 8612-8613 (2004). (Pubitemid 38955700)
66. Gruenhagen JA, Lai CY, Radu RD, Lin VSY, Yeung ES. Real-time imaging of tunable adenosine 5-triphosphate release from an MCM-41-type mesoporous silica nanosphere-based delivery system. Appl. Spectrosc. 59, 424-431 (2005). (Pubitemid 40538308)
67. Zhao Y, Trewyn BW, Slowing II, Lin VSY. Mesoporous silica nanoparticle-based double drug delivery system for glucose-responsive controlled release of insulin and cyclic AMP. J. Am. Chem. Soc. 131, 8398-8400 (2009).
68. Garcia-Bennett A, Nees M, Fadeel B. In search of the holy grail: folate-targeted nanoparticles for cancer therapy. Biochem. Pharmacol. 81(8), 976-984 (2011).
69. Lu J, Liong M, Li Z, Zink JI, Tamanoi F. Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals. Small 6(16), 1794-1805 (2010).
70. Giri S, Trewyn BG, Stellmaker MP, Lin YS. Stimuli-responsive controlled-release delivery system based on mesoporous silica nanorods capped with magnetic nanoparticle. Angewandte Chemie International Editions 44, 5038-5044 (2005). (Pubitemid 41188539)
71. Wu SH, Lin YS, Hung Y et al. Multifunctional mesoporous silica nanoparticles for intracellular labeling and animal magnetic resonance imaging studies. Chembiochem. 9(1), 53-57 (2008).
72. Liong M, Lu J, Kovochich M et al. Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery. ACS Nano 2(5), 889-896 (2008).
73. Silica, Colloidal Anhydrous, European Pharmacopoeia, 3rd Edition. 0434, 1469 (1997).
74. Witasp E, Kupferschmidt N, Bengtsson L et al. Efficient internalization of mesoporous silica particles of different sizes by primary human macrophages without impairment of macrophage clearance of apoptotic or antibody-opsonized target cells. Toxicol. Appl. Pharmacol. 239, 306-309 (2009).
75. Vallhov H, Gabrielsson S, Strømme M, Scheynius A, Garcia-Bennett AE. Mesoporous silica particles induce size dependent effects on human dendritic cells. Nano Lett. 7(12), 3576-3582. (2007).
76. Vivero-Escoto L, Slowing II, Trewyn BG, Lin VSY. Mesoporous silica nanoparticles for intracellular controlled drug delivery. Small 6(18), 1952-1967 (2010).
77. Hudson SP, Padera RF, Langer R, Kohane DS. The biocompatibility of mesoporous silica. Biomaterials 29, 4045-4055 (2008)
78. Kaewamatawong T, Kawamura N, Okajima M, Sawada M, Morita T, Shimada A. Acute pulmonary toxicity caused by exposure to colloidal silica: particle size dependent pathological changes in mice. Toxicol. Pathol. 33, 745-751 (2005). (Pubitemid 41759177)
79. Nagayama S, Ogawara K, Fukuoka Y, Higaki K, Kimura T. Time-dependent changes in opsonin amount associated on nanoparticles alter their hepatic uptake characteristics. Int. J. Pharm. 342, 215-221 (2007). (Pubitemid 47259322)
80. He Q, Shi J, Zhu M, Chen Y, Chen F. The three-stage in vitro degradation behavior of mesoporous silica in simulated body fluid. Microporous Mesoporous Mater. 131, 314-320 (2010).
81. He X, Nie H, Wang K, Tan W, Wu X, Zhang P. In vivo study of biodistribution and urinary excretion of surface-modified silica nanoparticles. Anal. Chem. 80, 9597-9603 (2008).
82. Burns A, Vider J, Ow H et al. Fluorescent silica nanoparticles with efficient urinary excretion for nanomedicine. Nano Lett. 9, 442-448 (2008).
83. Bagnato A, Natali PH. Endothelin receptors as novel targets in tumor therapy. J. Transl. Med. 2, 1-9 (2004).